March 2017 – Page 2 – Policy & Medicine

Deloitte Survey on Value-Based Care

Fourth Due Diligence Summit for Life Sciences

Will Trump Repeal Medical Device Taxes?

CMS Delays New Bundled Payments Model

Using the Crystal Ball: What Does the Future Hold for Life Science Compliance?

Dr. Janet Woodcock on the Opioid Epidemic

2016-2025 Projections of National Health Expenditures Data Released

Accountability: The shifting landscape of compliance responsibilities

Op-Ed in The Hill on Allowing Medicare to Directly Negotiate Drug Prices

Privacy Regulation: The Final Frontier of Life Science Compliance